Clinicians' attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations

MLA

S, Shkedi-Rafid, et al. “Clinicians’ Attitudes toward General Screening of the Ashkenazi-Jewish Population for Prevalent Founder BRCA1/2 and LRRK2 Mutations.” Public Health Genomics, vol. 16, no. 4, Jan. 2013. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........d9e0f1f1c5245bd783466aa375eb92af&authtype=sso&custid=ns315887.

APA

S, S.-R., G, O.-B., V, M., & R, C.-M. (2013). Clinicians’ attitudes toward general screening of the Ashkenazi-Jewish population for prevalent founder BRCA1/2 and LRRK2 mutations. Public Health Genomics, 16(4).

Chicago

S, Shkedi-Rafid, Ofer-Bialer G, Meiner V, and Calderon-Margalit R. 2013. “Clinicians’ Attitudes toward General Screening of the Ashkenazi-Jewish Population for Prevalent Founder BRCA1/2 and LRRK2 Mutations.” Public Health Genomics 16 (4). http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.pmid..........d9e0f1f1c5245bd783466aa375eb92af&authtype=sso&custid=ns315887.